Related Experiment Video
Updated: Jun 4, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling
1The State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Life Sciences, Tsinghua University, Beijing, China.
Abstract:
TGF-β (transforming growth factor-β) is a pleiotropic cytokine regulating diverse cellular processes. It signals through membrane-bound receptors, downstream Smad proteins and/or other signalling mediators. Smad7 has been well established to be a key negative regulator of TGF-β signalling. It antagonizes TGF-β signalling through multiple mechanisms in the cytoplasm and in the nucleus. Smad7 can be transcriptionally induced by TGF-β and other growth factors and serves as an important cross-talk mediator of the TGF-β signalling pathway with other signalling pathways. Accordingly, it plays pivotal roles in embryonic development and adult homoeostasis, and altered expression of Smad7 is often associated with human diseases, such as cancer, tissue fibrosis and inflammatory diseases.
Insights
Transforming growth factor-β (TGF-β) signaling is regulated by Smad7, a key negative regulator. Smad7 antagonizes TGF-β actions and influences development, homeostasis, and diseases like cancer and fibrosis.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Biochemistry
Background:
- Transforming growth factor-β (TGF-β) is a crucial cytokine involved in numerous cellular functions.
- TGF-β exerts its effects via membrane receptors and downstream signaling molecules, including Smad proteins.
- Smad7 is a well-established negative regulator of TGF-β signaling.
Purpose of the Study:
- To elucidate the multifaceted roles of Smad7 in TGF-β signaling.
- To understand Smad7's mechanisms of action in both the cytoplasm and nucleus.
- To highlight Smad7's significance as a cross-talk mediator and its implications in human diseases.
Main Methods:
- Analysis of Smad7's inhibitory mechanisms.
- Investigation of Smad7's transcriptional regulation by TGF-β and other growth factors.
- Review of Smad7's involvement in cellular processes and disease pathogenesis.
Main Results:
- Smad7 effectively antagonizes TGF-β signaling through diverse cytoplasmic and nuclear mechanisms.
- Smad7 expression is induced by TGF-β and other growth factors, indicating its role in pathway cross-talk.
- Altered Smad7 expression is linked to various human diseases, including cancer, fibrosis, and inflammation.
Conclusions:
- Smad7 is a pivotal negative regulator of TGF-β signaling with broad implications.
- Smad7's regulatory functions are critical for embryonic development and adult homeostasis.
- Dysregulation of Smad7 contributes to the pathogenesis of significant human diseases.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
TGF - β Signaling Pathway
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway